Ozark, congrats! There are still 3 weeks remaining in 2013 but I am ready to give you the award for 2013 message board dimwit of the year award. Yeah a guy who claims to have bought 2,000 shares of a $6 stock could be the biggest shareholder. That's great stuff. When heavy hitters say they "nibbled" on some stock, they mean they invested maybe $250K to dabble a bit. I know the major holders, millions of shares and it ain't him and won't be him. Your award will be mailed if you provide an address.
Thanks. I read it after I posted and saw that. I had 2500 shares, already reduced from the last reverse so I dumped it at 24 cents today. Beats the zero I will have holding worthless stock certs in a bogus private chinese company. The mystery to me is why anyone would buy 2500 shares at 24 cents which will essentially be worth zero shortly. Thanks though. $600 is better than zero, but the big loss to offset other gains
earth, I think 15 on its own is too high. Keep in mind you cannot justify MDXG's current stock price based on sales and certainly not on earnings. We will grow into our stock price next year but I think only the expansion beyond DFU and in to orthopedics, etc can get us to $15 without an acquisition and, that will take a while, a couple of years now working through the FDA. An large company will be willing to pay a nice premium to get MDXG but I don't think that Epifix alone can get is to $15.
Been in this for many years and honestly stopped following because the value of the investment at this point is so small. Am I correct that when the dust settles here we are supposed to get 50 cents per share cash based on our current holdings?
I thought you were going to tell us you withdrew it because you found out a buy out was coming after close today at $15 so your question was moot. :-)
Well, I will give you my thoughts not based on any proprietary information but just having been involved with Petit's companies over the years and considering his age and seemingly his frustrations dealing with Wall Street and the FDA. I do not view this as a long term play. I believe this is Petit's last build and sell and would guess that it will be sold in 2014 somewhere in the $12-$15 range.
(Reuters) - The planned sale of German medical skin patch maker LTS Lohmann has stalled due to a disagreement amongst its current owners over whether the bids are satisfactory, three people familiar with the matter said.
Swiss drugmaker Novartis holds a 43 percent stake in LTS Lohmann, while German billionaire Dietmar Hopp, who co-founded software giant SAP, holds about 30 percent. German investment company BWK owns a 24 percent stake.
"There is no shareholder agreement on the sell side (on the minimum asking price) and that is holding things up," one of the sources said. "The three shareholders have different interests."
Buyout firms Wendel of France and Nordic Capital of Sweden have put in bids valuing the company - the first to launch a nicotine patch in the U.S. in 1991 - at about 1.2 billion euros ($1.6 billion), sources said last month.
At least one of the owners is holding out for proceeds of 1.4 billion euros from the sale, one of the sources said.
Wendel, Nordic and BWK declined to comment on Thursday.
Officials at Novartis and a spokesman for Hopp's investment vehicle were not immediately available for comment.
The bids from Wendel and Nordic value the group at about 12.6 times earnings before interest, taxes, depreciation and amortisation (EBITDA) of about 95 million euros.
Listed healthcare companies in Europe trade at a multiple of about 11.5, data from Thomson Reuters StarMine show.
LTS Lohmann makes about 286 million euros in annual sales from nicotine and other medical patches to treat conditions including Parkinson's and Restless Legs Syndrome. ($1 = 0.7377 euros) (Reporting by Arno Schuetze, Claire Ruckin and Ludwig Burger; Editing by Victoria Bryan)
The large after hours black is simply an institution doing an arranged trade and that's the cross. Very common
You are correct. The final trade was 100 shares at 2.33. One other trade was 28,298 shares at $2.2435
ow, I'd be surprised if we ever get 2015 guidance from MDXG
earth, you are forgetting that this isn't the only p[art of MDXG's business and maybe not even the largest part of it
The link to the snipet is on Yahoo. I am trying to get the note
Nice try shorty, er honkass. Company blows away 2014 (current) guidance even if injectables were pulled pending IND. It's a non issue